The two therapies target different biological systems: tirzepatide modulates appetite hormones and glucose regulation, whereas Lipo B (if effective) would theoretically support mitochondrial energy production
GLP-1 therapy should complement, not replace, appropriate lipid-lowering treatment according to NICE guidance
Frequent and persistent infections due to compromised immune function
Anxiety responded first and time to remission occurred rapidly within 712 weeks, despite varied challenges, including preferences for time-restricted eating, slow adoption, inconsistent monitoring, and emergent fatigue during strenuous exercise, which occurred many weeks into KMT due to low serum carnitine and spontaneous reduction of protein intake rather than keto-adaptation or keto-flu. All patients improved metabolically, and one patient achieved optimal metabolic health (6)
Figure 1 In recent years, the human gut microbiota has gained significant attention, with metagenomic studies enhancing our understanding of its diverse species and potential applications in health (Gomaa and Gomaa, 2020)
